| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |